Korea-Registries to Overcome Dementia and Accelerate Dementia Research (K-ROAD): A Cohort for Dementia Research and Ethnic-Specific Insights

키워드

참고문헌 (53)

1. Ahn HJ, "Seoul Neuropsychological Screening Battery-dementia version(SNSB-D) : a useful tool for assessing and monitoring cognitive impairments in dementia patients", J Korean Med Sci, 25, pp.1071~1076 (2010)
2. Albert MS, "The diagnosis of mild cognitive impairment due to Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.270~279 (2011)
3. McKhann GM, "The diagnosis of dementia due to Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.263~269 (2011)
4. Petersen RC, "Mild cognitive impairment : a concept in evolution", J Intern Med, 275, pp.214~228 (2014)
5. Park JH, "Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment", Neurobiol Aging, 35, pp.254~260 (2014)
6. Kang SH, "Amyloid positivity in the Alzheimer", subcortical-vascular spectrum, 2021, pp.96, e2201~e2211
7. Armstrong MJ, "Criteria for the diagnosis of corticobasal degeneration", Neurology, 80, pp.496~503 (2013)
8. Gorno-Tempini ML, "Classification of primary progressive aphasia and its variants", Neurology, 76, pp.1006~1014 (2011)
9. Litvan I, "Clinical research criteria for the diagnosis of progressive supranuclear palsy(Steele-Richardson-Olszewski syndrome) : report of the NINDS-SPSP international workshop", Neurology, 47, pp.1~9 (1996)
10. Rascovsky K, "Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia", Brain, 134, pp.2456~2477 (2011)
11. Strong MJ, "Amyotrophic lateral sclerosis-frontotemporal spectrum disorder(ALS-FTSD) : Revised diagnostic criteria", Amyotroph Lateral Scler Frontotemporal Degener, 18, pp.153~174 (2017)
12. Kang Y, "Seoul Neuropsychological Screening Battery" (2003), Human Brain Research & Consulting Co
13. Kang SH, "The cortical neuroanatomy related to specific neuropsychological deficits in Alzheimer’s continuum", Dement Neurocogn Disord, 18, pp.77~95 (2019)
14. Kang Y, "Seoul Neuropsychological Screening Battery (SNSB-II)" (2012), Human Brain Research & Consulting Co
15. Ryu HJ, "The Seoul Neuropsychological Screening Battery(SNSB)for comprehensive neuropsychological assessment", Dement Neurocogn Disord, 22, pp.1~15 (2023)
16. Wechsler D, "Wechsler adult intelligence scale", Front Psychol (1955)
17. Kaplan E, "The Boston Naming Test" (1983), Lea & Febiger
18. Meyers J, "Rey Complex Figure Test and Recognition Trial" (1995), Psychological Assessment Resources, Inc
19. Benedict RH, "Hopkins Verbal Learning Test—revised : normative data and analysis of inter-form and test–retest reliability", Clin Neuropsychol, 12, pp.43~55 (1998)
20. Benton A, "Multilingual Aphasia Examination" (1983), AJA Associates
21. Golden CJ, "Stroop Color and Word Test. A Manual for Clinical and Experimental Uses" (1978), Stoelting Company
22. Folstein MF, ""Mini-mental state". A practical method for grading the cognitive state of patients for the clinician", J Psychiatr Res, 12, pp.189~198 (1975)
23. Morris JC, "The Clinical Dementia Rating(CDR) : current version and scoring rules", Neurology, 43, pp.2412~2414 (1993)
24. Kang Y, "A validity study on the Korean Mini-Mental State Examination(K-MMSE)in dementia patients", J Korean Neurol Assoc, 15, pp.300~308 (1997)
25. O’Bryant SE, "Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores : a Texas Alzheimer’s research consortium study", Arch Neurol, 65, pp.1091~1095 (2008)
26. Kim H, "Normative data on the Korean version of the Boston Naming Test", J Clin Exp Neuropsychol, 21, pp.127~133 (1999)
27. Klunk WE, "The Centiloid Project : standardizing quantitative amyloid plaque estimation by PET", Alzheimers Dement, 11, pp.1~15 (2015)
28. Kim SJ, "Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET", Alzheimers Res Ther, 14, pp.157~ (2022)
29. Chun MY, "Emerging role of vascular burden in AT(N)classification in individuals with Alzheimer’s and concomitant cerebrovascular burdens", J Neurol Neurosurg Psychiatry, 95, pp.44~51 (2023)
30. Zijdenbos AP, "Automatic"pipeline"analysis of 3-D MRI data for clinical trials : application to multiple sclerosis", IEEE Trans Med Imaging, 21, pp.1280~1291 (2002)
31. Collins DL, "Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space", J Comput Assist Tomogr, 18, pp.192~205 (1994)
32. Sled JG, "A nonparametric method for automatic correction of intensity nonuniformity in MRI data", IEEE Trans Med Imaging, 17, pp.87~97 (1998)
33. Kim J, "Motor symptoms in early-versus late-onset Alzheimer’s disease", J Alzheimers Dis, 91, pp.345~354 (2023)
34. Jack CR Jr, "An operational approach to National Institute on Aging-Alzheimer’s Association criteria for preclinical Alzheimer disease", Ann Neurol, 71, pp.765~775 (2012)
35. Jack CR Jr, "Different definitions of neurodegeneration produce similar amyloid", neurodegeneration biomarker group findings, 2015, pp.138, 3747~3759
36. Noh Y, "A new classification system for ischemia using a combination of deep and periventricular white matter hyperintensities", J Stroke Cerebrovasc Dis, 23, pp.636~642 (2014)
37. Wardlaw JM, "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration", Lancet Neurol, 12, pp.822~838 (2013)
38. Zammit MD, "PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome", Neuroimage, 228, pp.117728~ (2021)
39. Kim SJ, "Clinical and pathological validation of CT-based regional harmonization methods of amyloid PET", Clin Nucl Med, 49, pp.1~8 (2024)
40. Frangou S, "Hippocampal volume reduction is associated with direct measure of insulin resistance in adults", Neurosci Res, 174, pp.19~24 (2022)
41. Langella S, "The association between hippocampal volume and memory in pathological aging is mediated by functional redundancy", Neurobiol Aging, 108, pp.179~188 (2021)
42. "Access data and samples" (2023)[URL]
43. Weiner MW, "The Alzheimer’s disease neuroimaging initiative : progress report and future plans", Alzheimers Dement, 6, pp.202~211 (2010)
44. Kim HR, "Identifying novel genetic variants for brain amyloid deposition : a genome-wide association study in the Korean population", Alzheimers Res Ther, 13, pp.117~ (2021)
45. Kim SE, "A nomogram for predicting amyloid PET positivity in amnestic mild cognitive impairment", J Alzheimers Dis, 66, pp.681~691 (2018)
46. Kim JP, "Predicting amyloid positivity in patients with mild cognitive impairment using a radiomics approach", Sci Rep, 11, pp.6954~ (2021)
47. Kang SH, "Machine learning for the prediction of amyloid positivity in amnestic mild cognitive impairment", J Alzheimers Dis, 80, pp.143~157 (2021)
48. Chun MY, "Prediction of conversion to dementia using interpretable machine learning in patients with amnestic mild cognitive impairment", Front Aging Neurosci, 14, pp.898940~ (2022)
49. Kim KW, "Disease progression modeling of Alzheimer’s disease according to education level", Sci Rep, 10, pp.16808~ (2020)
50. Kim J, "Differential effects of risk factors on the cognitive trajectory of early-and late-onset Alzheimer’s disease", Alzheimers Res Ther, 13, pp.113~ (2021)
51. Jang H, "The impact of amyloid-β or tau on cognitive change in the presence of severe cerebrovascular disease", J Alzheimers Dis, 78, pp.573~585 (2020)
52. Jang H, "Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients", Eur J Nucl Med Mol Imaging, 47, pp.292~303 (2020)
53. Morris E, "Diagnostic accuracy of(18)F amyloid PET tracers for the diagnosis of Alzheimer’s disease : a systematic review and meta-analysis", Eur J Nucl Med Mol Imaging, 43, pp.374~385 (2016)

관련 논문AI추천